{
    "2021-04-02": [
        [
            {
                "time": "",
                "original_text": "带量采购下，多家药械企探索新模式",
                "features": {
                    "keywords": [
                        "带量采购",
                        "药械企业",
                        "新模式"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "国盛证券-医药生物行业周报：CXO成反弹先锋，耐心底部捡钻石；为什么说南新制药是低估的？【行业研究】",
                "features": {
                    "keywords": [
                        "国盛证券",
                        "医药生物",
                        "CXO",
                        "反弹",
                        "南新制药",
                        "低估"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}